Boston Partners decreased its stake in Invacare Co. (NYSE:IVC) by 15.4% during the 4th quarter, Holdings Channel reports. The fund owned 133,950 shares of the health services provider’s stock after selling 24,340 shares during the period. Boston Partners’ holdings in Invacare were worth $2,257,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. 1st Global Advisors Inc. acquired a new stake in shares of Invacare in the second quarter worth $138,000. Municipal Employees Retirement System of Michigan grew its stake in shares of Invacare by 63.1% in the third quarter. Municipal Employees Retirement System of Michigan now owns 12,360 shares of the health services provider’s stock worth $195,000 after acquiring an additional 4,780 shares during the last quarter. Fox Run Management L.L.C. acquired a new stake in shares of Invacare in the fourth quarter worth $238,000. Voya Investment Management LLC grew its stake in shares of Invacare by 10.5% in the second quarter. Voya Investment Management LLC now owns 17,271 shares of the health services provider’s stock worth $228,000 after acquiring an additional 1,648 shares during the last quarter. Finally, Thrivent Financial For Lutherans grew its stake in shares of Invacare by 7.7% in the second quarter. Thrivent Financial For Lutherans now owns 19,470 shares of the health services provider’s stock worth $257,000 after acquiring an additional 1,390 shares during the last quarter.
Shares of Invacare Co. (NYSE IVC) opened at $18.25 on Thursday. Invacare Co. has a 52 week low of $10.20 and a 52 week high of $19.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.54 and a current ratio of 2.10. The firm has a market cap of $719.08, a price-to-earnings ratio of -7.77 and a beta of 2.55.
Several brokerages have recently issued reports on IVC. ValuEngine upgraded shares of Invacare from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. KeyCorp restated a “buy” rating and issued a $20.00 price objective on shares of Invacare in a research note on Thursday, December 21st. Finally, Zacks Investment Research upgraded shares of Invacare from a “sell” rating to a “hold” rating in a research note on Wednesday, January 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $16.50.
WARNING: “Invacare Co. (IVC) Shares Sold by Boston Partners” was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.chaffeybreeze.com/2018/02/15/invacare-co-ivc-shares-sold-by-boston-partners.html.
Invacare Company Profile
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.